- Home
- GANX vs KG Comparison
GANX vs KG Comparison
Compare GANX & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GANX | KG |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.6M | 87.3M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GANX | KG |
|---|---|---|
| Price | $1.72 | $7.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 456.7K | 22.1K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.46 | ★ 1819.15 |
| EPS | ★ N/A | N/A |
| Revenue | $55,180.00 | ★ $34,049,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 785.08 |
| 52 Week Low | $1.53 | $6.72 |
| 52 Week High | $4.34 | $29.13 |
Technical Indicators
Market Signals| Indicator | GANX | KG |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 43.02 |
| Support Level | $1.71 | N/A |
| Resistance Level | $2.22 | $8.17 |
| Average True Range (ATR) | 0.09 | 0.53 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 1.67 | 46.79 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About KG Kestrel Group Ltd.
Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.